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In utero gene expression in the 
Slc39a8(neo/neo) knockdown 
mouse
Jing Chen  1, Marina Gálvez-Peralta  2,4, Xiang Zhang2, Jingyuan Deng2,5, Zijuan Liu3 & 
Daniel W. Nebert2
Slc39a8 encodes ZIP8, a divalent cation/bicarbonate symporter expressed in pluripotent mouse 
embryonic stem cells, and therefore ubiquitous in adult tissues; ZIP8 influxes Zn2+, Mn2+ and Fe2+. 
Slc39a8(neo/neo) knockdown mice exhibit 10–15% of wild-type ZIP8 mRNA and protein levels, and 
show pleiotropic phenotype of stunted growth, neonatal lethality, multi-organ dysmorphogenesis, and 
dysregulated hematopoiesis manifested as severe anemia. Herein we performed RNA-seq analysis of 
gestational day (GD)13.5 yolk sac and placenta, and GD16.5 liver, kidney, lung, heart and cerebellum, 
comparing Slc39a8(neo/neo) with Slc39a8(+/+) wild-type. Meta-data analysis of differentially-
expressed genes revealed 29 unique genes from all tissues — having enriched GO categories associated 
with hematopoiesis and hypoxia and KEGG categories of complement, response to infection, 
and coagulation cascade — consistent with dysregulated hematopoietic stem cell fate. Based on 
transcription factor (TF) profiles in the JASPAR database, and searching for TF-binding sites enriched by 
Pscan, we identified numerous genes encoding zinc-finger and other TFs associated with hematopoietic 
stem cell functions. We conclude that, in this mouse model, deficient ZIP8-mediated divalent cation 
transport affects zinc-finger (e.g. GATA proteins) and other TFs interacting with GATA proteins (e.g. 
TAL1), predominantly in yolk sac. These data strongly support the phenotype of dysmorphogenesis and 
anemia seen in Slc39a8(neo/neo) mice in utero.
Starting with a Cd2+-induced testicular necrosis phenotype and genetically “sensitive” vs “resistant” inbred mouse 
strains, this laboratory identified Slc39a8 (encoding the ZIP8 transporter) as the major gene responsible for this 
trait1–3. ZIP8 functions as a Zn2+/(HCO3−)2, Mn2+/(HCO3−)2 or Cd2+/(HCO3−)2 symporter, in each case moving 
all three ions of the complex into the cell in an electroneutral manner4. ZIP8 has also been shown to import diva-
lent iron and cobalt5. Moreover, ZIP8 transports selenium in the form of selenite into the cell — presumably as 
a Zn2+/(HCO3−)(HSeO3−) electroneutral complex6. In mammalian cell and Xenopus oocyte cultures, Mn2+ and 
Fe2+ are able to substitute for the Zn2+ cation5,7,8. It is possible that metal-ion specificity of ZIP8-mediated uptake 
in the intact animal might be dependent on organ and/or cell-type.
Developmentally, ZIP8 is expressed in mouse visceral endoderm at gestational day (GD)7.5 [ref.9], in the 
gastrula stage10, and in pluripotent embryonic stem cells11. These findings are compatible with the observation of 
early embryolethality, seen in Slc39a8(−/−) knockout mice when the gene is globally 100% ablated12.
During creation of a Slc39a8 conditional knockout construct12, the Frt-flanked neomycin-resistance 
mini-gene neo (transcribed in reverse orientation) was inserted into intron 3, combined with loxP sites in introns 
3 and 6. Fortuitous retention of the neo mini-cassette produced a unique hypomorph displaying 10–15% of 
wild-type levels of ZIP8 mRNA and protein in all tissues examined1–3. The Slc39a8(neo/neo) mouse has been 
extensively characterized: pleiotropic effects include stunted growth, neonatal lethality, shortened limbs and 
deformed skull, severe anemia, dysregulation of hematopoiesis, and multi-organ dysmorphogenesis; consistent 
with the severe anemia — striking decreases in size of placenta, and size and number of hematopoietic islands are 
seen in Slc39a8(neo/neo) GD13.5 yolk sac and placenta, as well as in GD16.5 liver13.
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A Slc39a8 inducible-global knockout and a Slc39a8 hepatocyte-specific conditional knockout, created inde-
pendently, exhibited striking decreases in Mn2+ concentrations in multiple organs tested; authors also found low-
ered levels of two Mn2+-dependent enzymes – arginase and β-1,4-galactosyltransferase activities – and evidence 
that hepatic ZIP8 rescues Mn2+ from bile and regulates whole-body Mn2+ homeostasis14. The Slc39a8 global 
knockout shows striking cardiac extracellular matrix accumulation, suggesting that Slc39a8 expression is essential 
for development of ventricular compaction15.
These mouse data1–16, summarized in Table 1, underscore the likely fundamental importance of ZIP8-mediated 
physiological functions in a large variety of tissues and cell-types. The gene was originally discovered in human 
monocytes17. More recently, a growing number of clinical studies of SLC39A8 variants have shown the pleio-
tropic effect of deficient ZIP8 function: during early development18–20 and in liver14,18,19, kidney21, lung22–25, heart/
cardiovascular system21,26–31, whole blood32, immune system17,22–25, brain20,33,34 including cerebellum18,19, eye35, 
gastrointestinal tract36, and musculoskeletal system18,19,37,38 (Table 1). In the present study, we chose to carry out 
RNA-seq analysis on seven tissues: GD13.5 yolk sac and placenta, plus GD16.5 fetal liver, kidney, lung, heart and 
cerebellum.
Results
Phenotype. Compared with Slc39a8(+/+) wild-type, the Slc39a8(neo/neo) fetuses and newborns were 
remarkably abnormal with dysmorphogenesis and severe anemia (Fig. 1); even placenta and yolk sac showed 
gross anemia13.
Analysis of differentially-expressed genes in individual tissues. Differential-expression analysis 
started with low-expression filtering, following which 6,249 genes were removed and 17,163 genes retained (hav-
ing CPM >1 in at least three samples). The number of significant differentially-expressed genes (Table 2) included 
15 in yolk sac, two in placenta, one in liver, 13 in lung, but none in kidney, heart and cerebellum. Two genes (Adh7 
and Zbtb8b) encode Zn2+-containing proteins. A heat map (Supplementary Data Figure S1) shows intensities of 
each gene expression.
In order to get sufficient numbers of differentially-expressed genes, a relaxed cut-off was used (significant 
at P < 0.05 and absolute fold-change >2) for all statistical functional enrichment analyses. KEGG pathways 
affected by differentially-expressed genes comprised: in yolk sac, two (“malaria” and “African trypanosomia-
sis”) down-regulated in Slc39a8(neo/neo) compared with wild-type; in kidney one down-regulated (“tight junc-
tion”); and in lung two down-regulated (“complement” and “coagulation cascades”) and one up-regulated 
(“Staphylococcus aureus infection”). Significant KEGG categories included “complement”, “response to infection”, 
and “coagulation cascade”. All these pathways are consistent with ZIP8 deficiency causing dysregulated hemato-
poietic stem cell fate in Slc39a8(neo/neo).
Global Transcriptome Analysis. RNA-seq analysis confirmed that expression intensities are distinctly dif-
ferent across the seven tissues examined (Fig. 2). Subsequently, global analysis revealed that the number of sig-
nificantly differentially-expressed genes totaled 695 for all tissues combined (Supplemental Table S1). There were 
646 unique genes. Gbp1 (guanylate-binding protein-1) was found differentially-expressed in five tissues; there 
were six genes in three tissues (Fig. 3A), and 33 genes in two tissues (Fig. 3B). This resulted in 40 genes (including 
Slc39a8) differentially-expressed in more than one tissue (Supplemental Table S2). The remaining 606 genes were 
differentially-expressed in only one tissue. Notable among the 40 genes are four Slc genes (other than Slc39a8) 
and two hemoglobin genes.
More than 80 differentially-expressed genes (Supplemental Table S1) were associated with hematopoiesis- and 
hypoxia-related functions (red font); these include all myelogenesis functions (e.g. cytokines, interferons, innate 
immunity, and inflammatory functions), because all are derived from hematopoietic stem cells. During mouse in 
utero development, hematopoiesis transitions from the aorta-gonad-mesonephros (AGM) region and yolk sac 
(between GD8 and GD13), then to liver (GD11 to GD20), and also to spleen (after GD15.5), and finally to bone 
marrow after GD17.5. Mouse (but not human) placenta is also a hematopoietic organ39.
Many other classes of genes that are seen (Supplemental Table S1) — includes those encoding: Zn2+-finger 
transcription factors (TFs) and homeobox and other very-early-embryonic functions associated with cell cycle 
and cell division; other Zn2+-containing proteins; proteins that are posttranslationally glycosylated; enzymes that 
participate in lipid and glucose homeostasis; growth factors (including several oncogenes and proto-oncogenes); 
and G-protein-coupled receptors. Nine cytochrome P450 (Cyp) genes, and 27 solute carrier (Slc) genes other 
than Slc39a8, were observed; explanations and speculations about members of these two gene superfamilies are 
discussed in Supplemental Table S1.
Systematic meta-analysis. Assuming each tissue is independent from all other tissues, we searched for 
differentially-expressed genes that tend to change in the same direction in all tissues. A meta-analysis based 
on Fisher’s combined probability test was applied to integrate empirical P-values across all tissues. Forty-seven 
genes tended to be consistently up- or down-regulated in all tissues (Supplemental Table S3). Not surprisingly, 
Slc39a8 was the most consistently down-regulated gene in all seven tissues with a combined P-value of 3.5e–04 
after FDR adjustment. Six hemoglobin genes were also significantly down-regulated. Heat maps illustrate the 45 
down-regulated genes in all tissues (Fig. 4A), and the two up-regulated in all tissues (Fig. 4B).
Among the statistically significant 45 genes being down-regulated, significantly enriched GO categories 
included: [a] “oxygen carrier activity” (GO:0005344) with Hbb-b1, Hbb-b2, and Hbb-y; [b] “homeostatic pro-
cesses” (GO:0042592) with Ahsg, Apob, Bpgm, Cps1, Dcn, Gpr65, Hba-a1, Hba-a2, Hbb-b1, Hbb-b2, Otc, Slc25a37, 
Slc39a8, Slc4a1, Slc8a1, and Snca; and [c] “hemoglobin complexes” (GO:0005833) with Hba-a1, Hba-a2, Hbb-b1, 
Hbb-b2, Hbb-bs, Hbb-y. The down-regulated genes in GO categories GO:0005344 and GO:0005833— plus the 
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four hemoglobin genes included in GO:0042592 category — provide further evidence indicating that globally 
diminished ZIP8-mediated function results in dysregulated essential hematopoiesis, leading to hypoxia.
Analysis of transcription factor (TF)-binding sites in genes identified by meta-analysis. 
Meta-analysis assumes there is a common impact of markedly decreased ZIP8 expression, genome-wide, across 
all tissues. Transcription is the first step in gene expression, and transcription is modulated by interaction of TFs, 
having their corresponding binding-sites within specific DNA modules of expressed genes.
After removing Slc39a8 from Pscan and searching for JASPAR TF motifs in promoter regions, and using 
a Bonferroni-corrected P-value of <0.1, among the “consistently down-regulated genes” discovered by 
meta-analysis (Supplementary Table S3), we found only two significant motifs — the Tal1::Gata1 heterodimer 
(JASPAR ID: MA0140.1) and Nfya (JASPAR ID: MA0060.1). TAL1 and GATA are of critical importance (vide 
infra). NFYA transcription factors participate in open chromatin of many types of stem cells — participating in 
differentiation, cell-cycle and transcriptional regulators, splicing and signaling factors, fatty acid and glucose 
homeostasis, and mitochondrial regulators40. Searching for JASPAR TF-binding sites, using the same criterion for 
the two “consistently up-regulated genes” (Supplemental Table S3), we found no significant motifs.
Analysis of TF-binding sites in individual tissues. Yolk Sac. Based on TF profiles in the JASPAR 
database, we searched in yolk sac for TF-binding sites enriched by Pscan (Table 3). We found nine up- and 
down-regulated genes having TF-binding sites significantly enriched in promoters: Plag1, Arnt, Hif1a, Znf423, 
Klf13, Sp1, Gata1, Gata2, and Gata4. Note that several TF-binding sites are duplicates with different matrix ID 
Organ or system Properties/Phenotypes of mammalian SLC39A8 gene (and its encoded ZIP8 transporter) References
Systemic
Mouse ZIP8 transports Zn2+, Mn2+, Cd2+/and probably Fe2+ and Co2+ — each presumanly as a 
M++/(HCO3−)2 electroneutral complex, moving ions into the cell; Slc39a8(neo/neo) knockdown 
fetus exhibits stunted growth, and neonatal lethality; Human SLC39A8 regulates manganese 
homeostasis and manganese-dependent enzyme activities, posttranslational glycosylation, and 
causes mitochondrial disorders; Mouse ZIP8 is required for Mn2+-dependent enzyme activities; 
Human SLC39A8 variant associated with increased body mass index
2,4,5,7,13,14,19,20,32,79
Developmental
Mouse Slc39a8 expressed in visceral endoderm at gestational day (GD)7.5, in the gastrula at 
earlier development, and expressed in pluripotent embryonic stem cells; Mouse Slc39a8(neo/
neo) global knockout is early embryo-lethal; Slc39a8(neo/neo) knockdown fetus exhibits multi-
organ dysmorphogenesis and decreases in size of placenta
9–13,18–20,80
Liver
Mouse Slc39a8(neo) allele is associated with highly significantly decreased liver size; Mouse 
ZIP8 transports selenium, presumably as a Zn2+/(HCO3−)(HSeO3−) electroneutral complex; 
Mouse hepatic ZIP8 rescues Mn2+ from bile, regulates whole-body Mn2+ homeostasis, and 
modulates activity of Mn2+-dependent enzymes
6,13,14,18,19
Kidney Mouse Slc39a8(neo) allele is associated with highly significantly decreased kidney size; Human SLC39A8 variant associated with blood pressure
13,21
Lung Mouse Slc39a8(neo) allele is associated with highly significantly decreased lung size; Human ZIP8 participates in Zn2+-mediated cytoprotection in lung inflammation
13,22,23
Cardiovascular system
Mouse Slc39a8(neo/neo) knockdown fetus shows trenda toward enlarged heart size; Human 
SLC39A8 variant associated with increased serum lipid levels, regulation of blood pressure, 
and risk of coronary artery disease; Human SLC39A8 variant associated with increased risk of 
acute coronary syndrome; Human SLC39A8 variant associated with increased risk of increased 
atherosclerosis in smokers; Mouse Slc39a8 is essential for cardiac ventricular compaction
13,15,21,26–31
Blood chemistry
Mouse Slc39a8(neo/neo) neonate shows significantly decreased total iron, total iron-binding 
capacity, serum ALT & AST levels,b and serum triglyceride levels; Human SLC39A8 variant 
associated with blood levels of toxic metals
13,32
Hematological system
Mouse Slc39a8(neo/neo) knockdown fetus exhibits severe anemia and dysregulation of 
hematopoiesis; Slc39a8(neo/neo) GD13.5 yolk sac and placenta shows smaller size and number 
of hematopoietic islands; Slc39a8(neo/neo) GD16.5 liver reveals decreased size and number of 
hematopoietic islands
13
Immune system
ZIP8 originally discovered in human monocytes; Human ZIP8 participates in Zn2+-mediated 
immune response to inflammation, participates in innate immune response to endotoxin-
induced macrophage inflammation, and host response in macrophages to Mycbacterium 
tuberculosis
17,22–25
Central nervous system
Mouse Slc39a8(neo/neo) knockdown fetus shows trenda in smaller size of cerebrum and 
cerebellum; Human SLC39A8 variant associated with increased risk of schizophrenia; Human 
SLC39A8 variant associated with impaired intellectual ability and cerebellar atrophy
13,18–20,33,34
Eye Human SLC39A8 variant associated with retinal iron accumulation 35
Spleen Mouse Slc39a8(neo) allele is associated with highly significantly decreased spleen size 13
Gastrointestinal tract Human SLC39A8 variant associated with Crohn disease and human gut microbiome composition
36
Musculoskeletal system
Mouse Slc39a8(neo/neo) knockdown fetus exhibits shortened limbs, and deformed skull; 
Human SLC39A8 variant associated with pathogenesis of osteoarthritis; Human SLC39A8 
variant associated with severe limb malformations
13,18,19,37,38
Reproductive system Mouse Slc39a8 variant is associated with Cd2+-induced testicular necrosis 1–3,16
Table 1. Properties and phenotypes reported, to date, for mammalian SLC39A8 gene. aThe term “trend’” 
denotes P-value > 0.05 < 0.10. bALT, alanine aminotransferase (common measurement used to assess damage 
largely in liver); AST, aspartate aminotransferase (common measurement used to assess damage in heart, 
skeletal muscle, kidney and brain, as well as liver.
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numbers. It is noteworthy that – except for Arnt and Hif1a, associated with the downstream hypoxic response 
[reviewed in41] — the remaining seven are Zn2+-finger TFs.
Pleomorphic adenoma gene-1 (Plag1) is one of three members in the PLAG family and is best known as an 
oncogene associated with certain cancers, most notably pleiomorphic tumors of salivary gland; PLAG1 partici-
pates in cell proliferation by directly regulating numerous target genes, including growth factors42. With regard to 
Znf423, Klf13 and Sp1 — there are about 515 Znf genes, 18 Klf genes, and nine Sp genes in mammalian genomes 
[https://www.genenames.org/]. With regard to Gata1, Gata2 and Gata4 — GATA factors (vide infra) are central 
to hematopoietic stem cell fate [reviewed in43].
Lung. We found 11 significant TF-binding sites in significantly enriched in promoters of up- and down-regulated 
genes (Table 3): Hnf4a, Hnf4g, Foxa2, Hnf1b, Hnf1a, Foxa1, Cux1, Cux2, Cebpe, Bhlha15, and Rxrg. Of these 
11 genes, the four Hnf genes encode Zn2+-finger TFs. The hepatocyte nuclear factor (Hnf) family comprises 
four members that contribute to innumerable critical-life processes. Forkhead genes, which previously had been 
termed Hnf genes, are now officially called Foxa1, Foxa2, Foxa3 and Foxm1 [https://www.genenames.org/]. Cux 
genes code for evolutionarily highly conserved homeobox-domain proteins44. With regard to Cebpe, Bhlha15 and 
Rxrg — CEBPE is a leucine-zipper TF associated with several myelogenous leukemias45, BHLHA15 is a member 
of the basic-helix-loop-helix (bHLH) family of TFs involved in numerous developmental programs46, and RXRG 
is a member of the nuclear receptor superfamily that also participates in many morphogenesis processes47.
Kidney. Prdm1 was the only TF-binding site significantly enriched in promoters of up- and down-regulated 
genes (Table 3). Prdm1 acts as a tumor suppressor gene involved in B-cell and T-cell lymphomas48; the PRDM 
family contains 15 members of epigenetic regulators that participate in autoimmune diseases and infections49.
Heart. Ebf1 was the only TF-binding site significantly enriched in promoters of up- and down-regulated genes 
(Table 3). EBF1 is regarded as a master regulator during B-cell differentiation and also plays a role in B-cell 
malignancies50.
Placenta, liver, and cerebellum. We found no statistically significant TF-binding sites as significantly enriched in 
promoters of up- and down-regulated genes in these tissues.
Discussion
Because ZIP8 is a known uptake transporter of Zn2+, Mn2+ and Fe2+ — functions of these divalent cations are 
briefly reviewed.
Zinc. Intracellular Zn2+ is critical in homeostasis-related signal transduction51, cell cycle and proliferation52, 
numerous processes that occur during development and differentiation, and maintenance of many Zn2+-requiring 
functions. In mammals there are >100 Zn2+-dependent enzymes53 and >2,000 Zn2+-containing TFs54. An inde-
pendent analysis estimated there are ~2,800 Zn2+-binding proteins, corresponding to ~10% of the human pro-
teome55. Because these enzymes and TFs carry out vital critical-life functions throughout development — often 
exerting cell-specific effects on morphogenesis, growth, and differentiation — an embryo’s ability to uphold Zn2+ 
homeostasis is essential from the single-cell-zygote stage onward56. Thus, when Slc39a8(neo/neo) is compared 
with Slc39a8(+/+), it is likely that many genes listed in Supplemental Table S1 are differentially-expressed as a 
direct, or indirect, manifestation of deficient ZIP8-mediated Zn2+ transport.
Manganese. Mn2+ is also a potent substrate for ZIP87,16. There are several known defects in ZIP-mediated 
Mn2+ transport [reviewed in57]. A human SLC39A8 nonsynonymous variant, resulting in decreased ZIP8 trans-
port, impairs the function of Mn2+-dependent enzymes — most notably β1,4-galactosyltransferase, essential 
for biosynthesis of the carbohydrate moiety of glycoproteins; compromised galactosylation in children causes 
a disorder with deformed skull, severe seizures, short limbs, profound psychomotor retardation, and hear-
ing loss19. Because numerous proteins are posttranslationally glycosylated, many genes listed in Supplemental 
Table S1 might be differentially-expressed as a reflection of defective ZIP8-mediated Mn2+ transport. There are 
no Mn2+-containing TFs.
Iron. ZIP8, along with its closest evolutionarily-related ZIP14 transporter, is a Fe2+-transport protein5,58. These 
data might be consistent with studies in the intact animal13 — showing that Slc39a8(neo/neo) fetuses exhibit dys-
regulated hematopoiesis — suggestive of an iron-transport defect. As noted (vide supra), Supplemental Table S1, 
highlighted in red font, lists >80 differentially-expressed genes associated with dysregulated hematopoietic 
stem cell fate and subsequent downstream events including hypoxia, when Slc39a8(neo/neo) is compared with 
wild-type; how many of these genes might reflect the importance of Fe2+ transport more so than Zn2+ transport, 
will require further studies. Although there are a few Fe2+-containing TFs in prokaryotes59, there are none in 
eukaryotes.
Emergence of several critical-life genetic networks. By comparing transcriptomes in the present 
study, specific genetic pathways are noteworthy (vide infra). There are two possibilities to explain emergence of 
these genetic pathways in response to globally deficient ZIP8-mediated transport. One, perhaps ZIP8-mediated 
divalent cation transport might be tissue- or cell type-specific — depending upon ZIP8 levels and the abundance 
of other redundant transport systems in each particular tissue or cell-type. In other words, it is possible that 
pathways affected by deficient ZIP8-mediated Zn2+ transport might be more significant in lung and kidney, those 
affected by diminished ZIP8-mediated Mn2+ transport might be more prominent in liver, and those affected 
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by deficient ZIP8-mediated Fe2+ transport might be more important in hematopoietic tissues. Two, it is pos-
sible that defective Zn2+ transport, primarily in early-embryo yolk sac, might override (i.e. occur upstream of) 
Mn2+-dependent and/or Fe2+-dependent gene products and their functions. These two possibilities will require 
further experiments, but the present study would argue in favor of the latter, i.e. defective Zn2+-finger TFs, pri-
marily in yolk sac, cause irreparable impairment of hematopoietic stem cell fate, which is then manifested — 
developmentally later — in the five fetal organs studied herein.
Fundamental Importance of TAL1. Tal1 was up-regulated in placenta and down-regulated in kidney 
(Supplementary Table S2). Differentially-expressed Gata genes were not seen among the 646 unique genes 
(Supplementary Table S1); this could reflect normal transcription, but then defective function due to its post-
translational Zn2+- and/or Mn2+-binding requirements. After searching JASPAR TF motifs in promoter regions, 
among “consistently down-regulated genes” by meta-analysis (Supplemental Table S3), we found the Tal1::Gata1 
heterodimeric complex (JASPAR ID: MA0140.1) as an important TF-binding motif. This finding is strengthened 
when we saw that TF-binding sites enriched by Pscan included Gata1, Gata2 and Gata4 in yolk sac (Table 3).
TAL1 is a bHLH TF that plays an important role in hematopoietic stem cell development60. GATA TFs are 
Zn2+-finger DNA-binding proteins that participate in various biological processes — including hematopoiesis 
and T-cell development [reviewed in ref.43]. Shifts in TAL1 occupancy of TF-binding sites during erythroid differ-
entiation are associated with gene repression (i.e. dissociation), and activation (i.e. co-occupancy with GATA1); 
in fact, recruitment by GATA TFs appears to be a stronger determinant of TAL1-binding to chromatin than the 
canonical E-box binding-site motif 61.
In order to validate the TAL1 result from PScan, we sought to perform an independent statistical test. From 
a list of manually-curated 80 TAL1-downstream targets62, we intersected the genes in this list with those in 
Supplemental Table S1 for all tissues (Supplemental Table S4). TAL1 targets were significantly enriched in yolk 
sac (Fisher’s exact test P = 1.178e–05), placenta (P = 4.982e–06), and marginally enriched in lung (P = 0.01895). 
Twelve hematopoiesis-related genes were seen, predominantly in yolk sac and placenta. Egln3 was the most 
strongly up-regulated gene in yolk sac; EGLN3 is a bHLH TF that responds to hypoxia by decreasing the produc-
tion of HIF-regulated angiogenic factors63. Cbfa2t3 was the most dramatically down-regulated gene in placenta; 
CBFA2T3 is clinically associated with several types of human leukemia. The only gene seen in heart was Zfpm1; 
ZFPM1 is a Zn2+-finger TF that (like TAL1) also forms heterodimers with TFs of the GATA family.
Moreover, TAL1 is known to activate Egln3, Hemgn and Ank162, and all were up-regulated in Slc39a8(neo/
neo) yolk sac. TAL1 represses Hbb-b262, which was down-regulated in Slc39a8(neo/neo) yolk sac (Supplemental 
Table S4). These data suggest that TAL1 protein activity might be increased in Slc39a8(neo/neo) yolk sac, whereas 
Tal1 gene differential expression was not seen. Similarly, in Slc39a8(neo/neo) placenta, Hemgn and Ank1 were 
up-regulated and Hbb-b2 down-regulated — suggesting that TAL1 protein might also be activated in that tissue.
None of the genes encoding Zn2+-finger TFs listed in Table 3 was differentially expressed to a level seen in 
Supplemental Table S1, i.e. these genes all appear to be transcribed somewhat normally. Thus, we suggest that, 
although transcription of these Zn2+-finger genes was within normal limits, only the protein functions of these 
Figure 1. Phenotype of Slc39a8(+/+), Slc39a8(+/neo), and Slc39a8(neo/neo) littermates. (A) GD16.5 pups 
with corresponding placentas below. Slc39a8(neo/neo) mice were remarkably abnormal – showing deformed 
skull and shortened limbs, as well as severe anemia, from the time during development that an embryonal sac 
can first be observed. (B) Newborns, postnatal day 1 – shortly before death of the Slc39a8(neo/neo) homozygote. 
Compared with Slc39a8(+/+) wild-type and Slc39a8(+/neo) heterozygotes that are pink in color and normal in 
size, the Slc39a8(neo/neo) littermates are extremely pale, show stunted growth, and deformed skulls and limbs. 
Slc39a8(neo/neo) liver, kidney, lung, spleen, cerebrum and cerebellum were all statistically significantly smaller 
in size than that in Slc39a8(+/+) or Slc39a8(+/neo) littermates13. For the RNA-seq analysis described herein, 
Slc39a8(+/neo) littermates were not studied.
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Gene symbol Official gene name
Average 
expression 
(RPKM)a
Fold-
Change
log2 Fold-
Change Pval Padj
GD13.5 YOLK SAC
bGbp1 guanylate-binding protein 1 15.1 19.23456 +4.265629 5.00E-05 0.070067
Stc2 stanniocalcin 2 28.3 15.36555 3.941627 1.25E-12 8.15E-09
2610528A11Rik RIKEN cDNA 2610528A11 gene 20.3 14.19895 3.827712 7.79E-10 3.05E-06
Gm853 predicted gene 853 17.5 9.210799 3.203326 1.74E-07 0.000487
Igfbp1 insulin-like growth factor-binding protein 1 248.6 7.475471 2.902165 2.08E-14 4.08E-10
cAdh7 alcohol dehydrogenase 7 (class IV), μ or σ polypeptide 41.1 7.286177 2.865162 1.67E-10 8.20E-07
cZbtb8b zinc-finger and BTB domain-containing 8b 22.7 5.996628 2.584151 2.51E-05 0.037875
Pkhd1l1 polycystic kidney and hepatic disease 1-like 1 246.1 4.879078 2.286609 1.09E-12 8.15E-09
Lancl3 LanC lantibiotic synthetase component C-like 3 (bacterial) 24.0 4.443403 2.151665 2.22E-05 0.037875
Reln Reelin 63.4 4.442197 2.151274 7.02E-05 0.091747
Egln3 EGL nine homolog 3 (C. elegans) 97.8 4.218064 2.076581 4.61E-09 1.51E-05
bHemgn Hemogen 56.0 3.825722 +1.935732 5.02E-07 0.001095
Slc30a10 solute carrier family 30, member 10 38.1 3.592453 +1.844969 2.38E-05 0.037875
Vldlr very-low-density lipoprotein receptor 278.3 3.005814 1.587756 2.19E-07 0.000538
bHbb-y hemoglobin Y, beta-like embryonic chain 19218.6 0.306581 −1.70566 2.09E-06 0.0041
GD13.5 PLACENTA
bHemgn hemogen 72.1 18.87205 +4.238179 2.15E-06 0.045538
bGbp1 guanylate-binding protein 1 51.3 5.689857 2.508392 6.52E-06 d 0.069045
GD16.5 LIVER
6030408B16Rik RIKEN cDNA 6030408B16 gene 693.3 0.179781 −2.47569 3.07E-06 d 0.061137
GD16.5 KIDNEY
NO SIGNIFICANT GENES FOUND
GD16.5 LUNG
bAfp alpha-fetoprotein 569.1 0.256586 −1.96249 5.30E-06 0.008782
Ahsg alpha-2-HS-glycoprotein 68.3 0.241724 −2.04857 6.85E-07 0.001512
Pzp pregnancy-zone protein 121.7 0.234948 −2.08958 2.53E-06 0.005029
Serpina1c serine (or cysteine) peptidase inhibitor, clade A, member 1C 25.8 0.224163 −2.15738 2.67E-05 0.040878
bFgg fibrinogen γ-chain 125.3 0.210643 −2.24712 1.10E-08 5.47E-05
Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B 40.9 0.210225 −2.24999 4.19E-07 0.001042
Ttr transthyretin 61.2 0.209949 −2.25189 8.56E-08 0.000272
bKng1 kininogen 1 41.5 0.196759 −2.34550 9.57E-08 0.000272
bFgb fibrinogen β-chain 96.2 0.195113 −2.35762 1.06E-10 2.11E-06
bFga fibrinogen α-chain 90.3 0.191209 −2.38678 3.55E-10 3.53E-06
Serpina6 serine (or cysteine) peptidase inhibitor, clade A, member 6 72.8 0.170657 −2.55083 4.07E-09 2.70E-05
bAmbp α1-microglobulin/bikunin 15.3 0.088155 −3.50381 3.98E-06 0.007188
Itih3 inter-α trypsin inhibitor, heavy chain 3 25.2 0.084581 −3.56353 2.61E-08 0.000104
GD16.5 HEART
NO SIGNIFICANT GENES FOUND
GD16.5 CEREBELLUM
NO SIGNIFICANT GENES FOUND
Table 2. Genes differentially regulated with FDR < 0.1, when comparing Slc39a8(neo/neo) with Slc39a8(+/+) 
wild-type. aRPKM, “number of Reads-Per-Kilobase-of-transcript-per-Million mapped reads”. bGenes that are 
erythropoiesis- and hypoxia-related – including those involved in iron transport; these also include all platelet 
and white-cell types and functions because all are derived from hematopoietic stem cells. cThese two genes 
encode Zn2+-containing proteins. ADH7 is an enzyme, and ZBTB8B is a Zn2+-finger TF. dAlthough 31 genes are 
listed, these two are not statistically significant (i.e. P > 0.05 when Padj is taken into account).
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Zn2+-finger TFs are the result of ZIP8 deficiency; in other words, postttranslational incorporation of Zn2+, and/
or deficient posttranslational glycosylation due to diminished Mn2+ levels, did not occur normally.
Fundamental Importance of GATA. The hematopoietically-expressed GATA family members of 
Zn2+-finger TFs are well known to function as key regulators of blood cell fate; for example, phenotypes of knock-
out mice — deficient in Gata1, Gata2, or Gata3 — suggest that these factors each play critical, but distinctly 
different, roles in hematopoiesis64. GATA2 mutations are clinically associated with familial myelodysplastic syn-
drome65,66, by affecting monocytes and/or B cells.
In order to validate the GATA1 result from Pscan (Table 3), we used a list of 512 GATA1-downstream target 
genes67; this list includes most of the well-established GATA1-mediated erythroid-specific targets, e.g. the Gata1 
gene itself, Gata2, the β-globin locus (specifically the locus-control region), Epor, Nfe2, Slc4a1, Gypa, Tal1, Lrf, 
Klf1, Nrf2, Runx1 and Alas2. We intersected the genes in this list with those in Supplemental Table S1 for all 
Slc39a8(neo/neo) tissues (Supplemental Table S5). Yolk sac was the tissue with the most enriched number of 
GATA1 targets: excluding Slc39a8, there were 13 differentially-expressed GATA1-downstream target genes out 
of the 512 total (Fisher’s exact test P = 0.001369). These findings provide strong evidence for key involvement of 
GATA1 in many of the differentially-expressed transcriptomic changes in Slc39a8(neo/neo) yolk sac.
We found no enrichment of GATA1 targets among differentially-expressed genes in liver, kidney, heart or cer-
ebellum. These data convincingly indicate that deficient ZIP8-mediated transport affects hematopoiesis-related 
processes primarily in yolk sac – as opposed to effects in placenta, or developmentally later, in early fetal liver.
Defective Hematopoiesis Leads to Hypoxia. Throughout our analysis presented herein, dysregulation 
of hematopoiesis-related stem cell functions is repeatedly described; decreases in hemoglobin content, red blood 
cell number, and iron uptake would likely elicit a “hypoxia signal” in many cell types – resulting in activation 
of hypoxic-response downstream-target genes. The striking anemia phenotype, seen in the earliest of visible 
Slc39a8(neo/neo) yolk sac, placenta, and embryos [Fig. 1 and ref.13], supports these findings.
A list of 87 manually-curated HIF-downstream targets68 has been reported; examples include genes involved 
in fatty acid and glucose homeostasis, glycolysis pathway, cell proliferation, cell migration, and angiogene-
sis. We intersected the genes in this list with those in Supplemental Table S1 for all Slc39a8(neo/neo) tissues 
(Supplemental Table S6). Fifteen differentially-expressed genes were detected in yolk sac (Fisher’s exact test 
P = 4.206e–15), one in kidney, two in lung, and none in placenta, liver, heart or cerebellum; as expected, all 15 of 
these were up-regulated (Supplemental Table S6). This independent statistical test confirms our Hif1a result from 
Pscan (Table 3).
In lung, Abcb1a was up-regulated; Cyp2s1 and Trf down-regulated. ABCB1A (“P-glycoprotein”) is 
up-regulated in response to many types of stress, including hypoxia69. In the presence of hypoxia, HIF1A/ARNT 
dimers are known to bind to an aryl hydrocarbon receptor response element (AHRE) upstream of the Cyp2s1 
gene70; furthermore, the Arnt::Hif1a heterodimer TF-binding site enriched by Pscan was found to be up-regulated 
in yolk sac (Table 3). Trf encodes transferrin, which is important in Fe2+ transport71; defective hematopoiesis 
resulting in anemia and subsequent hypoxia is the likely cause of down-regulation of Trf in lung.
In kidney one HIF-downstream target gene (Met up-regulated) was found. Met, a proto-oncogene, partici-
pates in angiogenesis – which would be stimulated by hypoxia72.
Figure 2. Characterization of Slc39a8(+/+) wild-type vs Slc39a8(neo/neo) mRNA expression levels in 
the seven tissues studied. Expression levels are indicated by RPKM, or “number of Reads-Per-Kilobase-of-
transcript-per-Million mapped reads.” This analysis takes into account the number of reads, normalized to 
size of the library, and transcriptional length of each gene. In all tissues, expression levels in Slc39a8(neo/
neo) samples were lower than those in Slc39a8(+/+) wild-type. Bars represent average mean values of three 
determinations, and brackets denote S.E.M.
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Hif1a expression itself was found not to be differentially-expressed in any tissue, whereas Hif3a was 
up-regulated in yolk sac (Supplementary Table S1). Hif1a and Hif3a in mice encode hypoxia-inducible TF sub-
units that respond to low oxygen (pO2) levels. Either of these TFs can bind as a heterodimeric complex with 
constitutively-expressed ARNT (aryl hydrocarbon receptor nuclear translocator), product of the Arnt gene.
Members of the Egl-9 family of HIF-inducible TFs (Egln1, Egln2 and Egln3) were also differentially-expressed 
(Supplemental Table S1). All six of these above-mentioned genes are members of the bHLH per-Arnt-sim (bHLH/
Figure 3. Heat maps plotting log2 fold-changes (FC) in differential expression. Using a cut-off of P < 0.05, and 
requiring absolute fold-change of >2.0, the Slc39a8 gene is also included. (A) Differentially-expressed genes 
in at least three tissues. (B) Differentially-expressed genes in at least two tissues. Two hemoglobin genes were 
significantly differentially down-regulated in all tissues except liver.
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PAS) family of TFs that detect endogenous and exogenous signals; the bHLH/PAS family contains at least 30 
members in the human and mouse genomes41. In fact, two other bHLH/PAS differentially-expressed genes 
(Bhlhe40 & Bhlhe41) were found to be up-regulated in yolk sac (Supplemental Table S1) – again supporting the 
theme of the Slc39a8(neo/neo) response to hypoxic stress.
Ingenuity Pathway Analysis. An independent Ingenuity Pathway Analysis (IPA) for the 165 differentially- 
expressed genes in yolk sac (Supplementary Table S7) revealed major pathways that were consistent with the 
Figure 4. Heat maps, plotting log2 fold-changes (FC). A FDR-adjusted meta-P-value of <0.1 was used. 
(A) Forty-five differentially-expressed genes that are consistently down-regulated in all tissues. (B) The two 
differentially-expressed genes that are consistently up-regulated in all tissues.
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data discussed throughout the text. Specifically, the top candidate from “Upstream Regulators Analysis” was the 
transcription factor HIF1A, and it is predicted to be activated. The top categories from the “Diseases and Bio 
Functions Analysis” included “Transport of molecule,” “Morphology of head,” “Glycolysis of cell,” “Morphology 
of nervous system,” and “Familial hemolytic anemia” — all of which confirms the data presented herein — as well 
as the associations of human SLC39A8 variants with most if not all of the clinical disorders (vide supra). With a 
FDR-adjusted P-value < 0.05 from “Canonical Pathway Analysis,” no significant canonical pathways were found.
Conclusions
A summary of many of these differentially-expressed genes, and their resultant effects, elicited by ZIP8 deficiency 
and described throughout this paper, is offered in Fig. 5.
To our knowledge, we know of no studies, reported to date, that dissect the mechanism behind why or how 
the knockdown of one critically important transporter gene can result in the up- and down-regulation of so many 
dozens of other transporter genes — and many of the transported moieties are not ions. These intriguing data 
represent many new avenues of possible experiments for future fascinating studies of whole-genome interactions.
TF Nameb Matrix ID Z Score P-value
Bonferroni 
P-value
UP-REGULATED IN YOLK SAC
Plag1 MA0163.1 5.12465 1.42E-07 9.00E-05
Arnt::Hif1a MA0259.1 5.09355 1.67E-07 0.000105754
Znf423 MA0116.1 4.17542 1.43E-05 0.009050338
Klf13 MA0657.1 4.16993 1.45E-05 0.009184069
Sp1 MA0079.3 4.04080 2.60E-05 0.016508603
Glis3 MA0737.1 3.69324 0.000107782 0.06844157c
DOWN-REGULATED IN YOLK SAC
Gata4 MA0482.1 4.80921 7.39E-07 0.000469005
Gata1 MA0035.3 4.57615 2.31E-06 0.001464596
Gata1 MA0035.2 4.12192 1.84E-05 0.011684635
Gata2 MA0036.2 3.84142 5.99E-05 0.03805663
UP-REGULATED IN KIDNEY
Prdm1 MA0508.1 3.81093 6.77507E-05 0.04302169
DOWN-REGULATED IN LUNG
Hnf4a MA0114.2 5.94132 1.30E-09 8.25E-07
Hnf4g MA0484.1 5.47657 2.01E-08 1.28E-05
Foxa2 MA0047.1 5.37203 3.64E-08 2.31E-05
Hnf4a MA0114.3 5.29283 5.63E-08 3.57E-05
Hnf1b MA0153.1 5.20468 9.09E-08 5.77E-05
Hnf1a MA0046.1 4.93196 3.75E-07 0.000238357
Foxa1 MA0148.1 4.85155 5.82E-07 0.000369529
Foxa1 MA0148.2 4.83018 6.48E-07 0.000411578
Hnf1b MA0153.2 4.7235 1.09E-06 0.000694766
Hnf4a MA0114.1 4.64095 1.64E-06 0.001038854
Hnf1a MA0046.2 4.51127 3.06E-06 0.00194136
Cux1 MA0754.1 4.01251 2.88E-05 0.018313464
Cux2 MA0755.1 3.9537 3.70E-05 0.02347703
Foxa2 MA0047.2 3.85396 5.64E-05 0.035813048
Foxa1 MA0148.3 3.72288 9.58E-05 0.060801885c
Cebpe MA0837.1 3.677 0.00011437 0.072621775c
Bhlha15 MA0607.1 3.60496 0.00015141 0.09614281c
Rxrg MA0856.1 3.60157 0.00015358 0.097521395c
UP-REGULATED IN HEART
Ebf1 MA0154.2 3.90828 4.56688E-05 0.02899969
Table 3. Significant transcription factor (TF)-binding sites in genes having differential-expression at P < 0.05 
and absolute fold-change >2; TF-binding site enrichment by Pscana. aUsing this rigorous method of analysis, we 
found no significant TF-binding sites in placenta, liver or cerebellum. bTF name denotes the TF-binding site(s) 
enriched by Pscan. cAlthough 30 enriched TF-binding sites are listed, these five are not statistically significant 
(i.e. P > 0.05 when the Bonferroni-corrected P-value is taken into account).
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Material and Methods
Animals. Cloning details for generating the viable Slc39a8(+/neo) heterozygous mouse line were described 
previously12. At 6–10 weeks of age, Slc39a8(+/neo) heterozygous males and females were bred. The morning 
on which the vaginal plug was found – was considered GD0.5. Individual Slc39a8(+/+), Slc39a8(+/neo) and 
Slc39a8(neo/neo) yolk sacs and placentas at GD13.5 were collected and genotyped; heterozygotes were discarded. 
Fetal liver, kidney, lung, heart and cerebellum at GD16.5 were also collected and genotyped.
All mouse experiments were conducted in accordance with the National Institutes of Health standards for the 
care and use of experimental animals. All experimental protocols were approved by the University of Cincinnati 
College of Medicine (IACUC) Institutional Animal Care and Use Committee [protocol #11-09-12-01].
Total RNA Extraction. RNeasy Micro kit (Qiagen) was used for total RNA extraction. Each sample, together 
with Buffer RLT, were added to ceramic-beads (1.4-mm) in tubes and homogenized by using the Precellys 
homogenizer (Cayman Chemical Company; Ann Arbor, MI). RNA extraction was then performed, following 
manufacturer’s recommendations.
RNA-Seq for differential gene expression profiling. For each RNA-seq sample, 1 μg RNA was used 
(which required two or more mice per sample). RNA-seq was performed at the Genomics, Epigenomics and 
Sequencing Core at the University of Cincinnati. To prepare the RNA library for sequencing, we used TruSeq 
RNA Library Prep Kit (Illumina; San Diego, CA), according to manufacturer’s instructions. In brief, poly(A+) 
RNA was purified from total RNA and then fragmented before cDNA synthesis. Double-strand cDNA fragments 
were then end-repaired and TA-ligated to the sequencing adapter; the specific index was added to the library dur-
ing the PCR amplification step. After 12 cycles of PCR enrichment, library quality was evaluated by a Bioanalyzer 
High Sensitivity chip and quantified by Kapa Library Quantification kit (Kapa Biosystem; Wilmington, MA), 
using the ABI 9700HT real-time PCR system (Thermo Fisher; Waltham, MA). Next, six individually indexed 
cDNA libraries were pooled in equal amounts for clustering in the cBot system (Illumina). Libraries were clus-
tered onto a flow cell at concentration of 15 pM, using Illumina’s TruSeq SR Cluster Kit v3, and then sequenced for 
50 cycles using TruSeq SBS kit on the Illumina HiSeq system. Each sample was expected to generate ~30 million 
reads.
Figure 5. Illustration of critically affected genes and their downstream effects that most closely fit the data 
presented in the present study. ZIP8 deficiency (top), has a major impact on TAL1 and GATA transcription 
factors (TFs), which appear to function primarily in the hematopoietic stem cells of Slc39a8(neo/neo) GD13.5 
yolk sac. This function then causes severe dysregulation of hematopoietic stem cell fate and striking anemia 
in yolk sac, which is visibly obvious [in Fig. S2 of ref.13]. Moreover, hematopoiesis in yolk sac is well known to 
precede that in liver and then spleen and marrow [cf. Fig. S4 of ref.13]. Downstream effects, as development 
proceeds, include severe anemia and defects in coagulation, innate immunity, and response to inflammation. 
The striking anemia leads to a hypoxia response which is seen in all tissues examined, but largely in yolk sac. 
TAL1, T-cell acute lymphocytic leukemia protein-1 TF. GATA, family of six zinc-finger TFs that regulate 
hematopoietic stem cell fate. Interactions between TAL1 and GATA exist61 [see text]. ZIP8-deficiency, plus 
the result of all these downstream changes, alter the expression of nine Cyp genes and 27 Slc genes (excluding 
Slc39a8); these changes are mostly unique to one tissue, as detailed in Supplementary Table S1. Δ denotes 
“changes in”. HIF, hypoxia-inducible factor.
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Bioinformatics analysis. Sequence reads were aligned to the genome by using the standard Illumina 
sequence analysis pipeline, which was analyzed by the Statistical Genomics and Systems Biology Core at the 
University of Cincinnati. Analyses included determinations of: [a] RNA-seq data quality control (QC) results; [b] 
all gene expression levels for the RNA samples; and [c] significantly differentially-expressed genes between the 
two groups, Slc39a8(neo/neo) vs Slc39a8(+/+). Genes with counts per million (CPM) >1 in at least three samples 
were used for further analysis. Differential expression analysis was performed using DESeq.73. The Benjamini–
Hochberg procedure74 was applied to adjust P-values for False Discovery Rate (FDR). Genes with FDR-adjusted 
P-values of <0.1 were considered as significantly differentially-expressed.
In addition to differential-expression analysis for individual tissues, meta-analysis was performed to identify 
genes that tend to change in the same direction across all tissues. The meta-analysis used Fisher’s combined 
probability test to integrate empirical P-values from all tissues. The empirical P-value for gene i in tissue j is 
defined as rij = rank(sij)/N, and sij = sign(fij) × [−log10(pij)], where fij is the log2 fold-change of gene i in tis-
sue j, pij the P-value of differential expression of gene i in tissue j, and N the total number of genes. See foot-
note of Supplemental Table S2 for a detailed description. The empirical P-value, based on gene rank, was less 
prone to an extreme effect in any individual tissue; thus, it was more robust, when compared with the original 
P-value from differential analysis. FDR-adjusted P-values of <0.1 were used as the cut-off for genes that tend to 
be differentially-expressed in all tissues.
Functional analysis of differentially-expressed genes was further performed. Because too few genes were sig-
nificant at FDR < 0.1, a less-stringent cut-off P-value of <0.05 and absolute fold-change of >2 was used, in order 
that a sufficient number of differentially-expressed genes could be used for statistical functional enrichment anal-
ysis. This would potentially result in a gene list having an increased number of false positives. Therefore, the 
purpose of the relaxed cut-off was to explore new hypotheses, rather than to derive individual candidate genes for 
validations. Specifically, MouseMine75 was used to identify significantly enriched gene ontology (GO) categories. 
Signaling-pathway impact analysis (SPIA) methodology76 – with number of differentially-expressed (NDE) genes 
>1; and FDR-corrected global P-value for each gene (pGFdr) <0.2 as cutoff] was used to identify significantly 
impacted Kyoto Encyclopedia of Genes and Genomes (KEGG)-signaling pathways. Ingenuity Pathway Analysis 
(IPA) was used to create the summary report and network figure.
In order to search for upstream regulators causing the observed changes in transcriptomes, 
the transcription-factor-binding site (TFBS) enrichment analysis was performed for promoters of 
differentially-expressed genes, as well as the significant genes from meta-analysis using Pscan77. For each TFBS, 
Pscan calculates a matching score for each promoter and compares the average matching score in a gene list vs 
those throughout the rest of the genome. If the average score is significantly higher in that gene list than the rest of 
the genome, then Pscan flags this TFBS as significant for this gene list. In this analysis, TF binding profiles in the 
JASPAR 2016 CORE database [http://jaspar.genered.net] was used, and promoter regions from −450 to +50 were 
considered. Significant TFBS genes were selected by Bonferroni corrected P-values of <0.1, as recommended by 
PScan.
All bioinformatics analyses, except for the tools mentioned above, were performed using the statistical com-
puting platform R, and heat maps were plotted using the R package ComplexHeatmap78. We have uploaded our 
Slc39a8 RNA-seq data onto Gene Expression Omnibus (GEO). The link to our dataset is https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE111080.
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